Literature DB >> 17391997

Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models.

Attila Gácser1, Wilhelm Schäfer, Jerome S Nosanchuk, Siegfried Salomon, Joshua D Nosanchuk.   

Abstract

Candida parapsilosis is an increasingly important human pathogen. To study the interactions of C. parapsilosis with human tissues, we evaluated the effects of the CBS 604 type strain and three different clinical isolates on reconstituted human oral epithelial and epidermal tissues. The newly described species Candida orthopsilosis and Candida metapsilosis were also examined in these models. Microscopy of reconstituted tissues infected with yeast cells revealed severe attenuation, morphological changes and cellular damage. C. orthopsilosis caused damage similar to C. parapsilosis isolates, whereas C. metapsilosis was less virulent. To further quantitate tissue damage, we measured lactate dehydrogenase (LDH) in the culture supernatant. The relative LDH measurements correlated with our histopathological observations. We also examined the effect of the lipase inhibitor Ebelactone B and proteinase inhibitor Pepstatin A, to establish the utility of this model for studying factors of C. parapsilosis virulence. Both Ebelactone B and Pepstatin A reduced the destruction of epidermal and epithelial tissues. Our data show that reconstituted human tissues are extremely useful for modeling host interactions with C. parapsilosis and for studying fungal virulence factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391997     DOI: 10.1016/j.fgb.2007.02.002

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  44 in total

1.  Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Authors:  Emilia Cantón; Javier Pemán; Guillermo Quindós; Elena Eraso; Ilargi Miranda-Zapico; María Álvarez; Paloma Merino; Isolina Campos-Herrero; Francesc Marco; Elia Gomez G de la Pedrosa; Genoveva Yagüe; Remedios Guna; Carmen Rubio; Consuelo Miranda; Carmen Pazos; David Velasco
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR.

Authors:  Ana Carolina R Souza; Renata C Ferreira; Sarah S Gonçalves; Guillermo Quindós; Elena Eraso; Fernando C Bizerra; Marcelo R S Briones; Arnaldo L Colombo
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

Review 3.  Bridging the gap between protein carboxyl methylation and phospholipid methylation to understand glucose-stimulated insulin secretion from the pancreatic beta cell.

Authors:  Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2007-06-28       Impact factor: 5.858

4.  Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species.

Authors:  C I Montero; Y R Shea; P A Jones; S M Harrington; N E Tooke; F G Witebsky; P R Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-04-18       Impact factor: 3.267

5.  Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species.

Authors:  Guillermo Garcia-Effron; Emilia Canton; Javier Pemán; Amanda Dilger; Eva Romá; David S Perlin
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

Review 6.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

Review 7.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.

Authors:  A Gomez-Lopez; A Alastruey-Izquierdo; D Rodriguez; B Almirante; A Pahissa; J L Rodriguez-Tudela; M Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

9.  Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.

Authors:  Ana P Silva; Isabel M Miranda; Carmen Lisboa; Cidália Pina-Vaz; Acácio G Rodrigues
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

10.  Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.

Authors:  Sara Gago; Rocío García-Rodas; Isabel Cuesta; Emilia Mellado; Ana Alastruey-Izquierdo
Journal:  Virulence       Date:  2013-11-05       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.